îæ€çŽ¢
îæ€çŽ¢
î
Quanterix Corp
QTRXîãŠã©ãããªã¹ãã«è¿œå
4.030USD
+0.200+5.22%
çµå€Â 08-07 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
189.84Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
詳现æ å ± Quanterix Corp äŒæ¥å
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Companyâs Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Quanterix Corp ãããã£ãŒã«
îäŒæ¥ã³ãŒãQTRX
äŒç€ŸåQuanterix Corp
äžå Žæ¥Dec 07, 2017
æé«çµå¶è²¬ä»»è
ãCEOãToloue (Masoud)
åŸæ¥å¡æ°471
蚌åžçš®é¡Ordinary Share
決ç®ææ«Dec 07
æ¬ç€Ÿæåšå°900 Middlesex Turnpike
éœåžBILLERICA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·01821
é»è©±çªå·16173019400
ãŠã§ããµã€ãhttps://www.quanterix.com/
äŒæ¥ã³ãŒãQTRX
äžå Žæ¥Dec 07, 2017
æé«çµå¶è²¬ä»»è
ãCEOãToloue (Masoud)
Quanterix Corpã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
159.60K
+3.43%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
23.88K
+48.29%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
15.04K
+53.67%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
159.60K
+3.43%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
23.88K
+48.29%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
15.04K
+53.67%
ãããã質å
Quanterix Corpã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îQuanterix Corpã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããDr. Masoud Toloue, Ph.D.
Quanterix CorpïŒQTRXïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãQuanterix Corpã®æ ªåŒãä¿æããŠããæ©é¢ã¯371瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ42.63Mã§ãå
šäœã®90.49%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯-4982326.00å¢å ããŠããŸãã
Quanterix Corpã®æ倧ã®åçæºã¯äœã§ããïŒ
î2026Q1ã«ãããŠãProduct revenueéšéãQuanterix Corpã«ãšã£ãŠæ倧ã®åçãçã¿åºããŠããããã®éé¡ã¯92.94Mã§ãå
šåçã®67.03%ãå ããŠããŸãã